Cytomegalovirus infections in the immunocompromised transplant patient. Prevention of cytomegalovirus disease with oral acyclovir

Transplant Proc. 1991 Apr;23(2 Suppl 1):17-9.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acyclovir / pharmacokinetics
  • Acyclovir / therapeutic use*
  • Administration, Oral
  • Cytomegalovirus Infections / prevention & control*
  • Humans
  • Immunotherapy
  • Kidney Transplantation*
  • Vaccines, Attenuated / therapeutic use

Substances

  • Vaccines, Attenuated
  • Acyclovir